Benzinga's Top Upgrades, Downgrades For October 28, 2020
Upgrades
For Omnicom Group Inc (NYSE: OMC), MoffettNathanson upgraded the previous rating of Sell to the current rating Neutral. Omnicom Group earned $1.21 in the third quarter, compared to $1.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of 82.73 and a 52-week-low of 46.37. Omnicom Group closed at $48.81 at the end of the last trading period.
For Advanced Micro Devices Inc (NASDAQ: AMD), Craig-Hallum upgraded the previous rating of Hold to the current rating Buy. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. At the moment, the stock has a 52-week-high of 94.28 and a 52-week-low of 31.83. Advanced Micro Devices closed at $78.88 at the end of the last trading period.
B. Riley FBR upgraded the previous rating for ViewRay Inc (NASDAQ: VRAY) from Neutral to Buy. For the second quarter, ViewRay had an EPS of $0.18, compared to year-ago quarter EPS of $0.32. The current stock performance of ViewRay shows a 52-week-high of 4.88 and a 52-week-low of 1.1055. Moreover, at the end of the last trading period, the closing price was at $3.00.
Deutsche Bank upgraded the previous rating for Lululemon Athletica Inc (NASDAQ: LULU) from Hold to Buy. For the second quarter, Lululemon Athletica had an EPS of $0.74, compared to year-ago quarter EPS of $0.96. The stock has a 52-week-high of 399.8965 and a 52-week-low of 128.845. At the end of the last trading period, Lululemon Athletica closed at $333.81.
According to JP Morgan, the prior rating for Xilinx Inc (NASDAQ: XLNX) was changed from Underweight to Neutral. Xilinx earned $0.79 in the second quarter, compared to $0.94 in the year-ago quarter. The stock has a 52-week-high of 130.4 and a 52-week-low of 67.68. At the end of the last trading period, Xilinx closed at $124.35.
JP Morgan upgraded the previous rating for Sherwin-Williams Co (NYSE: SHW) from Neutral to Overweight. In the third quarter, Sherwin-Williams showed an EPS of $8.29, compared to $6.65 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of 725.91 and a 52-week-low of 325.43. Moreover, at the end of the last trading period, the closing price was at $673.04.
For MSC Industrial Direct Co Inc (NYSE: MSM), Raymond James upgraded the previous rating of Underperform to the current rating Market Perform. In the fourth quarter, MSC Industrial Direct Co showed an EPS of $1.09, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of 79.87 and a 52-week-low of 44.93. MSC Industrial Direct Co closed at $67.72 at the end of the last trading period.
Barclays upgraded the previous rating for First Solar Inc (NASDAQ: FSLR) from Underweight to Equal-Weight. First Solar earned $1.45 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of 87.44 and a 52-week-low of 28.47. At the end of the last trading period, First Solar closed at $82.39.
For Advanced Micro Devices Inc (NASDAQ: AMD), Barclays upgraded the previous rating of Equal-Weight to the current rating Overweight. For the third quarter, Advanced Micro Devices had an EPS of $0.41, compared to year-ago quarter EPS of $0.18. The current stock performance of Advanced Micro Devices shows a 52-week-high of 94.28 and a 52-week-low of 31.83. Moreover, at the end of the last trading period, the closing price was at $78.88.
According to Keefe, Bruyette & Woods, the prior rating for Invesco Ltd (NYSE: IVZ) was changed from Market Perform to Outperform. For the third quarter, Invesco had an EPS of $0.53, compared to year-ago quarter EPS of $0.70. The stock has a 52-week-high of 19.01 and a 52-week-low of 6.375. At the end of the last trading period, Invesco closed at $13.96.
Downgrades
According to Craig-Hallum, the prior rating for Enphase Energy Inc (NASDAQ: ENPH) was changed from Buy to Hold. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The stock has a 52-week-high of 118.939 and a 52-week-low of 17.18. At the end of the last trading period, Enphase Energy closed at $98.63.
For Enphase Energy Inc (NASDAQ: ENPH), HC Wainwright & Co. downgraded the previous rating of Buy to the current rating Neutral. For the third quarter, Enphase Energy had an EPS of $0.30, compared to year-ago quarter EPS of $0.30. The current stock performance of Enphase Energy shows a 52-week-high of 118.939 and a 52-week-low of 17.18. Moreover, at the end of the last trading period, the closing price was at $98.63.
According to Goldman Sachs, the prior rating for Relmada Therapeutics Inc (NASDAQ: RLMD) was changed from Buy to Neutral. At the moment, the stock has a 52-week-high of 54.0 and a 52-week-low of 21.85. Relmada Therapeutics closed at $33.06 at the end of the last trading period.
For Exact Sciences Corp (NASDAQ: EXAS), Citigroup downgraded the previous rating of Buy to the current rating Neutral. In the third quarter, Exact Sciences showed an EPS of $0.07, compared to $0.31 from the year-ago quarter. The current stock performance of Exact Sciences shows a 52-week-high of 141.9 and a 52-week-low of 35.2512. Moreover, at the end of the last trading period, the closing price was at $131.12.
For Everbridge Inc (NASDAQ: EVBG), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. In the second quarter, Everbridge showed an EPS of $0.06, compared to $0.07 from the year-ago quarter. The current stock performance of Everbridge shows a 52-week-high of 165.79 and a 52-week-low of 66.19. Moreover, at the end of the last trading period, the closing price was at $128.68.
For Armstrong World Industries Inc (NYSE: AWI), B of A Securities downgraded the previous rating of Buy to the current rating Neutral. The stock has a 52-week-high of 111.46 and a 52-week-low of 61.56. At the end of the last trading period, Armstrong World Indus closed at $62.91.
According to Stifel, the prior rating for New Fortress Energy Inc (NASDAQ: NFE) was changed from Buy to Hold. New Fortress Energy earned $0.24 in the second quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of 54.92 and a 52-week-low of 7.01. New Fortress Energy closed at $49.16 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Harley-Davidson Inc (NYSE: HOG) was changed from Overweight to Equal-Weight. The stock has a 52-week-high of 40.86 and a 52-week-low of 14.31. At the end of the last trading period, Harley-Davidson closed at $35.37.
Evercore ISI Group downgraded the previous rating for Frontline Ltd (NYSE: FRO) from In-Line to Underperform. Frontline earned $1.04 in the second quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of 13.33 and a 52-week-low of 5.98. Frontline closed at $6.04 at the end of the last trading period.
According to JP Morgan, the prior rating for FB Financial Corp (NYSE: FBK) was changed from Neutral to Underweight. In the third quarter, FB Financial earned $1.46. At the moment, the stock has a 52-week-high of 40.33 and a 52-week-low of 14.38. FB Financial closed at $28.65 at the end of the last trading period.
Barclays downgraded the previous rating for Diamondback Energy Inc (NASDAQ: FANG) from Overweight to Equal-Weight. Diamondback Energy earned $0.15 in the second quarter, compared to $2.11 in the year-ago quarter. The stock has a 52-week-high of 96.92 and a 52-week-low of 14.55. At the end of the last trading period, Diamondback Energy closed at $26.57.
For DTE Energy Co (NYSE: DTE), BMO Capital downgraded the previous rating of Outperform to the current rating Market Perform. In the third quarter, DTE Energy showed an EPS of $2.61, compared to $1.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of 135.67 and a 52-week-low of 71.21. DTE Energy closed at $127.25 at the end of the last trading period.
According to Credit Suisse, the prior rating for Veoneer Inc (NYSE: VNE) was changed from Neutral to Underperform. In the third quarter, Veoneer showed an EPS of $0.96, compared to $1.20 from the year-ago quarter. The stock has a 52-week-high of 18.9 and a 52-week-low of 5.25. At the end of the last trading period, Veoneer closed at $15.83.
For Varian Medical Systems Inc (NYSE: VAR), Baird downgraded the previous rating of Outperform to the current rating Neutral. For the fourth quarter, Varian Medical Systems had an EPS of $1.12, compared to year-ago quarter EPS of $1.21. The stock has a 52-week-high of 176.19 and a 52-week-low of 89.62. At the end of the last trading period, Varian Medical Systems closed at $173.02.
According to Piper Sandler, the prior rating for Livongo Health Inc (NASDAQ: LVGO) was changed from Overweight to Neutral. For the third quarter, Livongo Health had an EPS of No EPS Value , compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of 151.049 and a 52-week-low of 18.76. Livongo Health closed at $142.89 at the end of the last trading period.
Initiations
UBS initiated coverage on Vertex Pharmaceuticals Inc (NASDAQ: VRTX) with a Buy rating. The price target for Vertex Pharmaceuticals is set to $287.00. Vertex Pharmaceuticals earned $2.61 in the second quarter, compared to $1.26 in the year-ago quarter. At the moment, the stock has a 52-week-high of 306.08 and a 52-week-low of 192.32. Vertex Pharmaceuticals closed at $212.19 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Terreno Realty Corp (NYSE: TRNO). The price target seems to have been set at $70.00 for Terreno Realty. Terreno Realty earned $0.19 in the second quarter, compared to $0.33 in the year-ago quarter. At the moment, the stock has a 52-week-high of 64.24 and a 52-week-low of 42.115. Terreno Realty closed at $58.25 at the end of the last trading period.
UBS initiated coverage on Sarepta Therapeutics Inc (NASDAQ: SRPT) with a Buy rating. The price target for Sarepta Therapeutics is set to $212.00. For the second quarter, Sarepta Therapeutics had an EPS of $1.51, compared to year-ago quarter EPS of $0.83. At the moment, the stock has a 52-week-high of 175.0 and a 52-week-low of 78.06. Sarepta Therapeutics closed at $139.62 at the end of the last trading period.
Berenberg initiated coverage on Rexford Industrial Realty Inc (NYSE: REXR) with a Buy rating. The price target for Rexford Industrial Realty is set to $56.00. For the third quarter, Rexford Industrial Realty had an EPS of $0.33, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of 53.48 and a 52-week-low of 31.7871. Rexford Industrial Realty closed at $47.69 at the end of the last trading period.
With a current rating of Buy, Berenberg initiated coverage on Plymouth Industrial REIT Inc (NYSE: PLYM). The price target seems to have been set at $15.00 for Plymouth Industrial REIT. Plymouth Industrial REIT earned $0.45 in the second quarter, compared to $0.43 in the year-ago quarter. At the moment, the stock has a 52-week-high of 21.4964 and a 52-week-low of 7.79. Plymouth Industrial REIT closed at $12.75 at the end of the last trading period.
UBS initiated coverage on PTC Therapeutics Inc (NASDAQ: PTCT) with a Neutral rating. The price target for PTC Therapeutics is set to $55.00. PTC Therapeutics earned $2.62 in the second quarter, compared to $0.75 in the year-ago quarter. The current stock performance of PTC Therapeutics shows a 52-week-high of 59.89 and a 52-week-low of 30.7923. Moreover, at the end of the last trading period, the closing price was at $53.26.
Berenberg initiated coverage on Monmouth Real Estate Investment Corp (NYSE: MNR) with a Buy rating. The price target for Monmouth Real Estate Inv is set to $17.00. For the third quarter, Monmouth Real Estate Inv had an EPS of $0.20, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of 15.53 and a 52-week-low of 8.42. At the end of the last trading period, Monmouth Real Estate Inv closed at $14.22.
With a current rating of Buy, UBS initiated coverage on Immunovant Inc (NASDAQ: IMVT). The price target seems to have been set at $61.00 for Immunovant. Immunovant earned $0.38 in the first quarter. The current stock performance of Immunovant shows a 52-week-high of 43.9399 and a 52-week-low of 8.34. Moreover, at the end of the last trading period, the closing price was at $42.93.
With a current rating of Neutral, UBS initiated coverage on Gilead Sciences Inc (NASDAQ: GILD). The price target seems to have been set at $61.00 for Gilead Sciences. Gilead Sciences earned No EPS Value in the third quarter, compared to $1.75 in the year-ago quarter. The current stock performance of Gilead Sciences shows a 52-week-high of 85.97 and a 52-week-low of 59.395. Moreover, at the end of the last trading period, the closing price was at $60.01.
With a current rating of Buy, B of A Securities initiated coverage on Cal-Maine Foods Inc (NASDAQ: CALM). The price target seems to have been set at $47.00 for Cal-Maine Foods. In the first quarter, Cal-Maine Foods showed an EPS of $0.40, compared to $0.94 from the year-ago quarter. At the moment, the stock has a 52-week-high of 46.6576 and a 52-week-low of 30.74. Cal-Maine Foods closed at $38.87 at the end of the last trading period.
With a current rating of Neutral, UBS initiated coverage on Biogen Inc (NASDAQ: BIIB). The price target seems to have been set at $268.00 for Biogen. Biogen earned $8.84 in the third quarter, compared to $9.17 in the year-ago quarter. The current stock performance of Biogen shows a 52-week-high of 374.99 and a 52-week-low of 254.925. Moreover, at the end of the last trading period, the closing price was at $255.30.
With a current rating of Neutral, UBS initiated coverage on Amgen Inc (NASDAQ: AMGN). The price target seems to have been set at $232.00 for Amgen. Amgen earned No EPS Value in the third quarter, compared to $3.66 in the year-ago quarter. The stock has a 52-week-high of 264.97 and a 52-week-low of 177.05. At the end of the last trading period, Amgen closed at $223.46.
With a current rating of Neutral, UBS initiated coverage on Alexion Pharmaceuticals Inc (NASDAQ: ALXN). The price target seems to have been set at $133.00 for Alexion Pharmaceuticals. In the second quarter, Alexion Pharmaceuticals showed an EPS of $3.11, compared to $2.64 from the year-ago quarter. The current stock performance of Alexion Pharmaceuticals shows a 52-week-high of 128.57 and a 52-week-low of 72.67. Moreover, at the end of the last trading period, the closing price was at $120.00.
With a current rating of Neutral, JP Morgan initiated coverage on Hyliion Holdings Corp (NYSE: HYLN). The price target seems to have been set at $27.00 for Hyliion Holdings. The stock has a 52-week-high of 44.9 and a 52-week-low of 20.4. At the end of the last trading period, Hyliion Holdings closed at $21.31.
Jefferies initiated coverage on Burlington Stores Inc (NYSE: BURL) with a Buy rating. The price target for Burlington Stores is set to $255.00. In the second quarter, Burlington Stores showed an EPS of $0.56, compared to $1.36 from the year-ago quarter. The stock has a 52-week-high of 250.89 and a 52-week-low of 105.67. At the end of the last trading period, Burlington Stores closed at $200.18.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
